Mcdonald Capital trims Regeneron stake by 10.6%
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
Mcdonald Capital Investors Inc. CA cut its Regeneron Pharmaceuticals (NASDAQ:REGN) stake by 10.6% in the third quarter, selling 20,389 shares, while still holding 172,649 shares valued at Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context